Timothy D. Henry
Elite in Angina
Check Dr. Timothy D. Henry's experience treating your condition:
About Dr. Timothy D. Henry

Timothy Henry is an Interventional Cardiologist and a Cardiologist in Cincinnati, Ohio. Henry has been practicing medicine for over 41 years and is rated as an Elite expert by MediFind in the treatment of Angina. He is also highly rated in 27 other conditions, according to our data. His top areas of expertise are Heart Attack, Angina, Cardiogenic Shock, Percutaneous Coronary Intervention (PCI), and Bone Marrow Aspiration. He is licensed to treat patients in Minnesota. Henry is currently accepting new patients.

His clinical research consists of co-authoring 461 peer reviewed articles and participating in 16 clinical trials in the past 15 years. In particular, he has co-authored 55 articles and participated in 6 clinical trials in the study of Angina.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Timothy D. Henry it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
2123 Auburn Ave, Suite 100, Cincinnati, OH 45219
Background & Education
Graduate Institution
University Of California, San Francisco School Of Medicine, 1982
Interventional Cardiology
Internal Medicine in MN
Hospital Affiliations
Mercy Health - West Hospital
Mercy Health - Anderson Hospital
The Christ Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

15 Clinical Trials

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Phase 1 Open Label, Dose Escalation Trial of Intracoronary Infusion of NAN-101 in Subjects With NYHA Class III Heart Failure
A Double-Blind, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of CLBS16 in Subjects With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
Catheter-based Transendocardial Delivery of Autologous Bone Marrow-Derived Cells in Patients With Heart Failure Due to Dilated Cardiomyopathy
ST Segment Detection Study
A Prospective, Double-Blind, Randomized, Placebo-controlled Clinical Trial of Intracoronary Infusion of Mesenchymal Precursor Cells (MPC) in the Treatment of Patients With ST-Elevation Myocardial Infarction
Human Recombinant Fibroblast Growth Factor-1 (FGF-1), for the Treatment of Subjects With Severe Coronary Heart Disease, a Placebo Controlled, Double-blind, Dose-varying Study
View 13 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors